Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser. (2021)
Attributed to:
Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bjophthalmol-2020-315836
PubMed Identifier: 32532760
Publication URI: http://europepmc.org/abstract/MED/32532760
Type: Journal Article/Review
Volume: 105
Parent Publication: The British journal of ophthalmology
Issue: 4
ISSN: 0007-1161